Friday, December 5, 2025

Seeking Alpha: Caci Intl ‘very likely’ to bid for Perspecta after Veritas deal, Stifel says

  • “Caci International (NYSE:CACI) is likely to counterbid for Perspecta (NYSE:PRSP) after the company agreed to a deal to sell to Veritas for $29.35/share earlier today, according to Stifel.”
  • “Veritas deal for Perspecta not a surprise, though the price is “more favorable” than expected, which suggests Veritas is a aware of “incremental interest” from other bidders which likely required a “more competitive” offer, according to Stifel analyst Joe Denardi.”
  • “Continues to expect that Veritas and CACI are most interested buyers with SAIC (NYSE:SAIC) and other PE firms as less likely…” Read the full article here.

Source: Caci Intl ‘very likely’ to bid for Perspecta after Veritas deal, Stifel says – By Josh Fineman, January 27, 2021. Seeking Alpha.

CACI and Perspecta were named to the updated list of NXT UP firms poised to make big waves in the Federal sector in 2020 and for years to come.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Innovation in Action: Advancing Government Health with Philips

FORUM is proud to partner with Philips for a series of articles on their groundbreaking innovations in health technology that serve public- and private sector citizens and service members. Please take a look to learn more about how Philips is advancing modern and efficient health care, while improving lives for generations to come.

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required